The company has submitted a Phase III protocol for a second product, acyclovir Lauriad®, an oral herpes treatment. Approval was granted in Australia, ...
The company has submitted a Phase III protocol for a second product, acyclovir Lauriad(R), an oral herpes treatment. Approval was granted in Australia, ...
Transport's lead product, the SoloVir(TM) electrokinetic transdermal system, utilizes the company's proprietary five-percent acyclovir gel-formulation to ...